An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device. / Valenzuela, Reuben M.; Rai, Ruju; Kirk, Brian H.; Sanders, Jessica N.; Sundar, Subhashree; Hamann, Steffen; Warner, Judith E.A.; Digre, Kathleen B.; Crum, Alison V.; Jones, Kirtly P.; Katz, Bradley J.

In: Neuro-Ophthalmology, Vol. 41, No. 4, 2017, p. 192-197.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Valenzuela, RM, Rai, R, Kirk, BH, Sanders, JN, Sundar, S, Hamann, S, Warner, JEA, Digre, KB, Crum, AV, Jones, KP & Katz, BJ 2017, 'An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device', Neuro-Ophthalmology, vol. 41, no. 4, pp. 192-197. https://doi.org/10.1080/01658107.2017.1304425

APA

Valenzuela, R. M., Rai, R., Kirk, B. H., Sanders, J. N., Sundar, S., Hamann, S., Warner, J. E. A., Digre, K. B., Crum, A. V., Jones, K. P., & Katz, B. J. (2017). An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device. Neuro-Ophthalmology, 41(4), 192-197. https://doi.org/10.1080/01658107.2017.1304425

Vancouver

Valenzuela RM, Rai R, Kirk BH, Sanders JN, Sundar S, Hamann S et al. An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device. Neuro-Ophthalmology. 2017;41(4):192-197. https://doi.org/10.1080/01658107.2017.1304425

Author

Valenzuela, Reuben M. ; Rai, Ruju ; Kirk, Brian H. ; Sanders, Jessica N. ; Sundar, Subhashree ; Hamann, Steffen ; Warner, Judith E.A. ; Digre, Kathleen B. ; Crum, Alison V. ; Jones, Kirtly P. ; Katz, Bradley J. / An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device. In: Neuro-Ophthalmology. 2017 ; Vol. 41, No. 4. pp. 192-197.

Bibtex

@article{dce042e5f6e34a77b030f740b7afaf34,
title = "An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device",
abstract = "Because of a previous association of pseudotumor cerebri (PTC) with levonorgestrel, we wished to evaluate the use of levonorgestrel-eluting intrauterine devices (“levonorgestrel intrauterine systems”, LNG-IUS) in our University of Utah and Rigshospitalet PTC patients. In our retrospective series, PTC prevalence was approximately 0.18% and 0.15% in the LNG-IUS population versus 0.02% and 0.04% in the non-LNG-IUS population (Utah and Rigshospitalet, respectively), with no significant differences in PTC signs and symptoms among the two groups. Our investigation suggests that women with an LNG-IUS may have increased risk of developing PTC but does not suggest an LNG-IUS can cause PTC.",
keywords = "Contraception, idiopathic intracranial hypertension, intrauterine system, levonorgestrel, pseudotumor cerebri",
author = "Valenzuela, {Reuben M.} and Ruju Rai and Kirk, {Brian H.} and Sanders, {Jessica N.} and Subhashree Sundar and Steffen Hamann and Warner, {Judith E.A.} and Digre, {Kathleen B.} and Crum, {Alison V.} and Jones, {Kirtly P.} and Katz, {Bradley J.}",
year = "2017",
doi = "10.1080/01658107.2017.1304425",
language = "English",
volume = "41",
pages = "192--197",
journal = "Neuro-Ophthalmology",
issn = "0165-8107",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device

AU - Valenzuela, Reuben M.

AU - Rai, Ruju

AU - Kirk, Brian H.

AU - Sanders, Jessica N.

AU - Sundar, Subhashree

AU - Hamann, Steffen

AU - Warner, Judith E.A.

AU - Digre, Kathleen B.

AU - Crum, Alison V.

AU - Jones, Kirtly P.

AU - Katz, Bradley J.

PY - 2017

Y1 - 2017

N2 - Because of a previous association of pseudotumor cerebri (PTC) with levonorgestrel, we wished to evaluate the use of levonorgestrel-eluting intrauterine devices (“levonorgestrel intrauterine systems”, LNG-IUS) in our University of Utah and Rigshospitalet PTC patients. In our retrospective series, PTC prevalence was approximately 0.18% and 0.15% in the LNG-IUS population versus 0.02% and 0.04% in the non-LNG-IUS population (Utah and Rigshospitalet, respectively), with no significant differences in PTC signs and symptoms among the two groups. Our investigation suggests that women with an LNG-IUS may have increased risk of developing PTC but does not suggest an LNG-IUS can cause PTC.

AB - Because of a previous association of pseudotumor cerebri (PTC) with levonorgestrel, we wished to evaluate the use of levonorgestrel-eluting intrauterine devices (“levonorgestrel intrauterine systems”, LNG-IUS) in our University of Utah and Rigshospitalet PTC patients. In our retrospective series, PTC prevalence was approximately 0.18% and 0.15% in the LNG-IUS population versus 0.02% and 0.04% in the non-LNG-IUS population (Utah and Rigshospitalet, respectively), with no significant differences in PTC signs and symptoms among the two groups. Our investigation suggests that women with an LNG-IUS may have increased risk of developing PTC but does not suggest an LNG-IUS can cause PTC.

KW - Contraception

KW - idiopathic intracranial hypertension

KW - intrauterine system

KW - levonorgestrel

KW - pseudotumor cerebri

U2 - 10.1080/01658107.2017.1304425

DO - 10.1080/01658107.2017.1304425

M3 - Journal article

C2 - 29344058

AN - SCOPUS:85017623884

VL - 41

SP - 192

EP - 197

JO - Neuro-Ophthalmology

JF - Neuro-Ophthalmology

SN - 0165-8107

IS - 4

ER -

ID: 197005086